AzTrials
AzTrials

DiabetesNCT00869609

Evaluation of Group Lifestyle Balance Maintenance Strategies

A study testing GLB Traditional Maintenance (TM) and GLB-Carb-focused Maintenance (CF) in people with Diabetes, run by University of Pittsburgh at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Heart disease is a leading cause of death in people in the United States. It is a major problem for those with diabetes. Conditions called the metabolic syndrome and pre-diabetes increase risk for diabetes and heart disease. The metabolic syndrome is a group of disorders that occur at the same time. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Diabetes
What is being tested?
GLB Traditional Maintenance (TM) and GLB-Carb-focused Maintenance (CF)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
Mar 2009to Aug 2010
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Non-diabetic patients with metabolic syndrome AND/OR pre-diabetes are eligible for this project based on the following criteria:
  • Metabolic Syndrome:
  • Patients with BMI ≥ 25 kg/m2, with at least 3 of the following risk factors for metabolic syndrome:
  • Waist circumference (>40 inches men, >35 inches women)
  • Blood pressure ≥130 mmHg (systolic) or ≥85 mmHg (diastolic) OR history of diagnosed hypertension
  • Low HDL level (<40mg/dL men, <50 mg/dL women)
Show all 11Show fewer
  • Elevated triglyceride level ≥150 mg/dL
  • Fasting glucose ≥100mg/dL and <126mg/dL
  • Pre-diabetes:
  • Patients with a BMI ≥25 kg/m2 and pre-diabetes (fasting glucose ≥100 mg/dL and <126mg/dL)
  • All measures should have been taken within one year of enrollment into the study. A permission for physical activity form must be signed by the participant's physician in order to take part in the study.

Who cannot join

  • Previous diabetes or diabetes diagnosed as a result of the screening
  • Age <18 years old
  • Women who are currently (or within past 6-weeks) pregnant or lactating
  • Any patient deemed by their physician not to be a candidate
  • Any patient planning to leave the area before the end of the GILS
  • Any patient who is unable to provide informed consent

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Diabetes Prevention Support Center

    Pittsburgh, Pennsylvania, 15213

Other trials in United States

About this study

Heart disease is a leading cause of death in people in the United States. It is a major problem for those with diabetes. Conditions called the metabolic syndrome and pre-diabetes increase risk for diabetes and heart disease. The metabolic syndrome is a group of disorders that occur at the same time. Overall, one in four American adults has the metabolic syndrome. It is more common in people over the age of 40. The metabolic syndrome includes: 1) large waist size, 2) high triglycerides, 3) low HDL cholesterol, 4) high blood pressure and 5) high fasting blood sugar. People with the metabolic syndrome have at least three of these five risk factors. Pre-diabetes is considered to be present in those with high fasting blood sugar levels below the diabetes range.

Research has shown that type 2 diabetes and the metabolic syndrome may be prevented or delayed by making lifestyle changes. It is not known what will most help people continue these healthy changes over time. The purpose of this study is to look at ways to help people continue the healthy lifestyle changes they have made while taking part in a diabetes prevention program called Group Lifestyle Balance (GLB).

Read the detailed description

Objective: To determine the effectiveness of the Group Lifestyle Balance (GLB) program with an added maintenance component focusing on carbohydrate reduction and hunger management when compared to the GLB program with traditional maintenance.

Research Design and Methods: The original Diabetes Prevention Program intervention was modified from a 16 session individual intervention to a 12 session group-based program called Group Lifestyle Balance (GLB). The Diabetes Prevention Support Center (DPSC) has been created to oversee the implementation of diabetes prevention and CVD risk reduction in various community settings. GLB is a 12-session group based program that focuses on a low fat diet, weight loss and physical activity. This evidence-based intervention is directed at those with pre-diabetes and/or the metabolic syndrome. A monthly maintenance component will be added which provides support in assisting individuals who have completed the 12-session course in the maintenance of healthy lifestyle changes.

The efficacy (in terms of weight reduction) of an added maintenance component focusing on carbohydrate reduction and hunger management will be compared to traditional maintenance. Participants will be randomly assigned to either GLB traditional maintenance (GLB-TM) or GLB and carbohydrate reduced maintenance (GLB-CRM). There will be two groups of approximately 15 subjects in each intervention assignment, for a total of approximately 30 subjects per intervention group and approximately 60 subjects taking part overall. Efficacy in both groups will be assessed by pre and post-intervention measures of diet (weight loss) and physical activity (the keystones of the intervention), as well as the achievement of the two goals: a 7% weight loss by the end of 6 months and 150 minutes of physical activity per week. Secondary outcomes to be evaluated include the reduction of global CVD risk, as assessed by the Framingham Score, the presence of metabolic syndrome (NCEP ATP III), and a fall in blood sugar. Repeat measures will be obtained at six months and one year for further evaluation and comparison.

Conditions
Diabetes
Being tested
GLB Traditional Maintenance (TM), GLB-Carb-focused Maintenance (CF)
Keywords
Diabetes Prevention, CVD Risk Reduction, Lifestyle Intervention
Medical subject headings
Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GLB Traditional Maintenance (TM)Behavioural

    After completion of the GLB 12 core sessions, participants will be randomly assigned to either Group Lifestyle Balance (GLB) program traditional maintenance or GLB Carb-focused maintenance. Participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information on healthy carbohydrate intake and hunger management.

  • GLB-Carb-focused Maintenance (CF)Behavioural

    After completion of the GLB 12 core sessions, participants will be randomly assigned to either Group Lifestyle Balance (GLB) program traditional maintenance or GLB Carb-focused maintenance. GLB-CF participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information on healthy carbohydrate intake and hunger management.

Study groups in NCT00869609
Study groupRoleWhat they receive
GLB Traditional Maintenance (TM)Active comparatorGroup Lifestyle Balance (GLB) program Traditional Maintenance: After completion of the GLB 12 core sessions, participants who are randomly assigned to GLB program Traditional Maintenance (TM) will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions.
Receives: Behavioral: GLB Traditional Maintenance (TM)
GLB-Carb-focused Maintenance (CF)Active comparatorGroup Lifestyle Balance (GLB) program Carb-focused Maintenance: After completion of the GLB 12 core sessions, participants randomly assigned to GLB Carb-focused Maintenance (CF) will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information regarding healthy carbohydrate intake and hunger management.
Receives: Behavioral: GLB-Carb-focused Maintenance (CF)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Weight

    Weight was measured twice without shoes with the average computed; participants were asked to remove their shoes at each measure.

    Measured: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

Secondary outcomes (9)
  1. Change in Total Cholesterol

    Total cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

    Measured: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  2. Change in HDL Cholesterol

    High-density lipoprotein (HDL) cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

    Measured: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  3. Change in LDL Cholesterol

    Low-density lipoprotein (LDL) cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

    Measured: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  4. Change in Triglycerides

    Triglycerides were measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

    Measured: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  5. Change in Fasting Glucose

    Fasting plasma glucose was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

    Measured: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  6. Change in Glycosylated Hemoglobin A1c (HbA1c)

    Collected via venous blood draw, the HbA1c level reflects glucose concentration over the previous period (approximately 8-12 weeks, depending on the individual) and provides an indication of long-term glycemic control.

    Measured: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  7. Change in Systolic Blood Pressure

    Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading.

    Measured: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  8. Change in Diastolic Blood Pressure

    Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading.

    Measured: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  9. Change in Waist Circumference

    Waist circumference was measured at the midpoint between the lower rib margin and the iliac crest; the measurement was repeated twice and the average computed.

    Measured: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Mar 2009 (estimated)
  2. Study startMar 2009
  3. Primary completionAug 2010
  4. Study completionAug 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00869609
Sponsor's protocol ID
PRO08120047
Status last verified
May 2016
First submitted
24 Mar 2009
Last updated
24 Jun 2016
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing GLB Traditional Maintenance (TM) and GLB-Carb-focused Maintenance (CF) in people with Diabetes, run by University of Pittsburgh at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 9 Feb 2016). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Weight (time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in